Canada Markets closed

RetinalGenix Technologies Inc. (RTGN)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
9.400.00 (0.00%)
At close: 04:03PM EST
Full screen
Trade prices are not sourced from all markets
Previous Close9.40
BidN/A x N/A
AskN/A x N/A
Day's Range9.40 - 9.40
52 Week Range3.00 - 20.00
Avg. Volume4
Market Cap162.358M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire

    Presenting on the Emerging Growth Conference on October 26 Register Now

    Niche Companies in, Technology, Transportation, Biotech, Mining, MedTech, Logistics, and HealthcareMIAMI, Oct. 25, 2022 (GLOBE NEWSWIRE) -- a leading independent small cap media portal with an extensive history of providing unparalleled content for the Emerging Growth Companies and Markets announces the Schedule of the 43rd Emerging Growth Conference on October 26, 2022. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong manageme

  • GlobeNewswire

    RetinalGeniX Technologies, Inc. to Present at the Emerging Growth Conference Wednesday, October 26, 2022

    RetinalGeniX Technologies Invites Individual and Institutional Investors, Advisors, and Analysts, to Attend its Real-Time, Interactive Presentation at The Emerging Growth ConferencePETALUMA, Calif., Oct. 24, 2022 (GLOBE NEWSWIRE) -- RetinalGeniX Technologies, Inc. OTCQB: RTGN to Present at the Emerging Growth Conference. RetinalGeniX Technologies, Inc. (RTGN) is pleased to announce that it has been invited to present a 30 - minute investor overview at the Emerging Growth Conference on Wednesday,

  • GlobeNewswire

    Vinay Mehindru, MD, MBA Appointed to RetinalGenix Technologies Inc. Board of Directors

    Appointment Expected to Support Initiatives to Improve Population Health Management and the Company’s Planned Listing Upgrade from OTCBQB to NASDAQ Vinay Mehindru joins Retinalgenix Board of Directors Vinay Mehindru, MD, MBA PETALUMA, Calif., July 26, 2022 (GLOBE NEWSWIRE) -- RetinalGenix™ Technologies, Inc. (OTCQB:RTGN) (“RetinalGenix” or the “Company”), announced today the appointment of Vinay Mehindru, MD, MBA to the RetinalGenix Technologies, Inc. Board of Directors. Dr. Mehindru is a multi-